Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study. [electronic resource]
Producer: 20190731ISSN:- 1399-3003
- Administration, Inhalation
- Aged
- Bronchodilator Agents -- administration & dosage
- Budesonide -- administration & dosage
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Forced Expiratory Volume -- drug effects
- Formoterol Fumarate -- administration & dosage
- Humans
- Internationality
- Male
- Metered Dose Inhalers
- Middle Aged
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.